- Home
- INAB vs MLSS Comparison
INAB vs MLSS Comparison
Compare INAB & MLSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | INAB | MLSS |
|---|---|---|
| Founded | 2016 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Specialties |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 22.9M | 22.9M |
| IPO Year | 2021 | 1995 |
Fundamental Metrics
Financial Performance| Metric | INAB | MLSS |
|---|---|---|
| Price | $2.67 | $0.29 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $108.00 | $1.00 |
| AVG Volume (30 Days) | ★ 734.9K | 516.4K |
| Earning Date | 11-06-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $8,929,517.00 |
| Revenue This Year | N/A | $8.95 |
| Revenue Next Year | N/A | $7.51 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 0.59 |
| 52 Week Low | $1.17 | $0.23 |
| 52 Week High | $12.53 | $1.39 |
Technical Indicators
Market Signals| Indicator | INAB | MLSS |
|---|---|---|
| Relative Strength Index (RSI) | 68.29 | 44.54 |
| Support Level | $2.10 | $0.28 |
| Resistance Level | $2.55 | $0.30 |
| Average True Range (ATR) | 0.27 | 0.03 |
| MACD | 0.02 | 0.00 |
| Stochastic Oscillator | 96.20 | 80.13 |
Price Performance
Historical ComparisonAbout INAB IN8bio Inc.
IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous, and genetically modified gamma-delta T cells. Its product candidates include INB-400, for the treatment of newly diagnosed glioblastoma, or GBM, INB-100 for the treatment of patients with high-risk leukemias undergoing hematopoietic stem cell transplantation, and other product candidates such as INB-200, INB-300, and INB-500.
About MLSS Milestone Scientific Inc.
Milestone Scientific Inc is a biomedical technology company. The company is engaged in pioneering proprietary, technological systems and solutions for the medical and dental markets. The company develops, manufactures, markets, and sells the computer-controlled system for the improved and painless delivery of local anesthetics. The system is marketed in dentistry under the trademark CompuDent and in medicine under the trademark CompuMed. The Company conducts its business through two reportable segments: Dental and Medical.